TABLE 2.
Clinical characteristics of subjects by pathogen group detected
| AdV n (%) | hMPV n (%) | PIV n (%) | RV n (%) | EV n (%) | RSV n (%) | IV n (%) | CoV n (%) | Atypical bacteria n (%) | |
|---|---|---|---|---|---|---|---|---|---|
| Number of patients | 55 | 63 | 113 | 285 | 110 | 99 | 83 | 44 | 15 |
| Median age (months) | 25 | 24 | 18 | 17 | 24 | 18 | 27 | 17 | 14 |
| Male, n (%) | 34 (62) | 33 (52) | 65 (58) | 143 (50) | 60 (54) | 59 (60) | 41 (49) | 23 (52) | 9 (60) |
| Mean symptom duration (days) | 2.5 | 3 | 2.8 | 2.9 | 2.4 | 2.8 | 2.7 | 2.6 | 3.9 |
| Symptoms | |||||||||
| Fever | 49 (89) | 56 (89) | 91 (81) | 215 (75) | 99 (89) | 83 (84) | 77 (93) | 33 (75) | 15 (100) |
| Nasal congestion | 55 (100) | 63 (100) | 106 (93) | 278 (98) | 111 (100) | 99 (100) | 81 (98) | 42 (95) | 11 (73) |
| Cough | 48 (87) | 57 (90) | 98 (87) | 218 (76) | 100 (90) | 97 (98) | 70 (84) | 35 (80) | 8 (53) |
| Wheeze | 32 (58) | 26 (41) | 65 (58) | 101 (35) | 78 (70) | 73 (74) | 44 (53) | 16 (36) | 0 |
| Clinical diagnosis | |||||||||
| Upper respiratory infection | 31 (56) | 42 (67) | 63 (56) | 217 (76) | 45 (41) | 31 (31) | 58 (59) | 33 (75) | 4 (27) |
| Laryngotracheitis | 9 (16) | 9 (14) | 16 (14) | 33 (12) | 18 (16) | 12 (12) | 15 (18) | 8 (18) | 1 (7) |
| Nasopharyngitis | 21 (38) | 31 (49) | 14 (12) | 156 (55) | 23 (21) | 14 (14) | 40 (48) | 20 (45) | 3 (20) |
| Influenza‐like illness | 1 (2) | 2 (3) | 6 (5) | 28 (10) | 4 (4) | 5 (5) | 3 (4) | 5 (11) | 0 |
| Lower respiratory infection | 25 (45) | 21 (33) | 46 (41) | 61 (21) | 65 (59) | 67 (68) | 24 (29) | 12 (27) | 10 (67) |
| Bronchiolitis | 22 (40) | 19 (30) | 43 (38) | 52 (18) | 60 (54) | 61 (62) | 22 (27) | 10 (23) | 8 (53) |
| Bronchitis | 1 (2) | 0 | 2 (2) | 4 (1) | 0 | 1 (1) | 0 | 0 | 0 |
| Pneumonia | 2 (4) | 2 (3) | 1 (1) | 5 (2) | 5 (5) | 5 (5) | 2 (2) | 2 (5) | 2 (13) |
| Antibiotics prescribed | 15 (27) | 10 (16) | 12 (11) | 34 (12) | 18 (16) | 27 (27) | 15 (18) | 3 (7) | 4 (27) |
Abbreviations: AdV, adenovirus; CoV, coronavirus; EV, enterovirus; hMPV, human metapneumovirus; IV, influenza virus; PIV, parainfluenza virus; RSV, respiratory syncytial virus; RV, rhinovirus.